Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...

Research at imec shows that a 3D-integrated charge-coupled-device (CCD)-based memory with IGZO conduction channel is an excellent candidate.

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

Inari has been the stronger player in PE, with better than 70% share. Importantly, the VTE market remains significantly underpenetrated, with only about 15% to 20% adoption in the U.S. and lower ...

Portage: Stryker, a medical technologies company, has announced a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. for $80 per share in ...

Shares of Inari Medical, Inc. (NASDAQ:NARI) jumped by 22.23 percent or $14.45 to close at $79.45 apiece after medical device maker Stryker on Monday announced that it would acquire the company for ...

NEW YORK: Medical-device maker Stryker has agreed to acquire Inari Medical, which makes devices that treat patients with venous diseases, in an all-cash deal worth US$4.9bil. The deal for Inari ...

Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion. Inari stock catapulted Tuesday on the news.

New York: Medical-device maker Stryker on Monday agreed to acquire Inari Medical, which makes devices that treat patients with venous diseases, in an all-cash deal worth $4.9 billion. The deal for ...

We've tried and tested the best streaming devices, from under £40, to make your TV smart and give you access to online content Although BBC iPlayer was one of the first streaming services to ...

Stryker will acquire Inari in an all-cash deal for $80 per share, valuing it at roughly $4.9 billion. The deal for the vascular medical device maker was first reported by Reuters Monday afternoon ...

Canaccord downgraded Inari Medical (NARI) to Hold from Buy with a price target of $80, up from $74, after Stryker (SYK) entered into a definitive agreement to acquire Inari in cash for $80 per share.